Samantha J Provost

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Protein Protein

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, Dillon R Flebbe, Shayne F Andrew, Samantha J Provost, Lauren McCormick, Alex Van Ry, Elizabeth McCarthy, John-Paul M Todd, Saran Bao, I-Ting Teng, Shir Marciano, Yinon Rudich, Chunlin Li, Shilpi Jain, Bushra Wali, Laurent Pessaint, Alan Dodson, Anthony Cook, Mark G Lewis, Hanne A Elyard, Jiri Zahradnik, Mehul S Suthar, Martha C Nason, Kathryn E Foulds, Peter D Kwong, Mario Roederer, Gideon Schreiber, Robert A Seder, Daniel C Douek
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways. Nature communications 15 (1) (2024)
Matthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, Dillon R Flebbe, Shayne F Andrew, Samantha J Provost, Lauren McCormick, Alex Van Ry, Elizabeth McCarthy, John-Paul M Todd, Saran Bao, I-Ting Teng, Shir Marciano, Yinon Rudich, Chunlin Li, Shilpi Jain, Bushra Wali, Laurent Pessaint, Alan Dodson, Anthony Cook, Mark G Lewis, Hanne A Elyard, Jiri Zahradnik, Mehul S Suthar, Martha C Nason, Kathryn E Foulds, Peter D Kwong, Mario Roederer, Gideon Schreiber, Robert A Seder, Daniel C Douek
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways. Nature communications 15 (1) (2024)
Matthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, Dillon R Flebbe, Shayne F Andrew, Samantha J Provost, Lauren McCormick, Alex Van Ry, Elizabeth McCarthy, John-Paul M Todd, Saran Bao, I-Ting Teng, Shir Marciano, Yinon Rudich, Chunlin Li, Shilpi Jain, Bushra Wali, Laurent Pessaint, Alan Dodson, Anthony Cook, Mark G Lewis, Hanne A Elyard, Jiri Zahradnik, Mehul S Suthar, Martha C Nason, Kathryn E Foulds, Peter D Kwong, Mario Roederer, Gideon Schreiber, Robert A Seder, Daniel C Douek
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways. Nature communications 15 (1) (2024)
Matthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, Dillon R Flebbe, Shayne F Andrew, Samantha J Provost, Lauren McCormick, Alex Van Ry, Elizabeth McCarthy, John-Paul M Todd, Saran Bao, I-Ting Teng, Shir Marciano, Yinon Rudich, Chunlin Li, Shilpi Jain, Bushra Wali, Laurent Pessaint, Alan Dodson, Anthony Cook, Mark G Lewis, Hanne A Elyard, Jiri Zahradnik, Mehul S Suthar, Martha C Nason, Kathryn E Foulds, Peter D Kwong, Mario Roederer, Gideon Schreiber, Robert A Seder, Daniel C Douek
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways. Nature communications 15 (1) (2024)
Matthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, Dillon R Flebbe, Shayne F Andrew, Samantha J Provost, Lauren McCormick, Alex Van Ry, Elizabeth McCarthy, John-Paul M Todd, Saran Bao, I-Ting Teng, Shir Marciano, Yinon Rudich, Chunlin Li, Shilpi Jain, Bushra Wali, Laurent Pessaint, Alan Dodson, Anthony Cook, Mark G Lewis, Hanne A Elyard, Jiri Zahradnik, Mehul S Suthar, Martha C Nason, Kathryn E Foulds, Peter D Kwong, Mario Roederer, Gideon Schreiber, Robert A Seder, Daniel C Douek
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways. Nature communications 15 (1) (2024)